Potential risks may include: Overdosing, which may lead to symptoms such as nausea, vomiting, or other adverse effects
These differences are attributable to factors stemming from historic racial discrimination, including differences in insurance coverage and income, since for those who do not have coverage, the retail cost of these medications is roughly $1,000 per month
Third, it causes nausea in a meaningful percentage of users, particularly during the first few weeks of treatment
So when Mounjaros maker, Eli Lilly, sued Empower last month for selling knockoff versions, the Houston pharmacy portrayed the case as Big Pharma testing its power against companies like them, who prioritize personalized, affordable care over profit. But a decade of documented regulatory violations and a former high-ranking employees recent allegation that Empower used subpar ingredients to make drugs complicates that message and raises broader questions about Empowers adherence to federal rules designed to ensure quality and safety
It comes from an early study on binding affinity that was later called into question and never fully verified
Regular monitoring of weight, body measurements, and symptoms is essential, with professional support from registered dietitians for optimal outcomes and safety